Table 5.

Summary of trials investigating lamivudine prophylaxis^a for chemotherapy-related HBV reactivation

^aDose of lamivudine used in all studies was 100 mg/day except where otherwise noted.

Abbreviations: HBsAg, hepatitis B surface antigen; NR, not reported; (+), positive; (−), negative.